Parse Biosciences

About Parse Biosciences

Parse Biosciences is a leading provider of accessible and scalable single cell sequencing solutions. Their mission is to advance research by offering instrument-free, high-scale single cell sequencing technology, enabling researchers to achieve unprecedented discoveries with ease and flexibility.

Products & Services

Evercode WT Mini:Designed for starting single cell transcriptomics, profiling up to 10,000 cells and 1-12 samples.

Evercode WT Mega:Scales single cell projects to 100,000-1,000,000 cells and 1-384 samples in a single experiment.

Evercode BCR:Captures full-length BCR sequences and gene expression for 10,000-1,000,000 cells and 1-96 samples.

Evercode Fixation:Enables sample fixation for increased flexibility in single cell experiments.

Gene Select:Offers targeted gene panels to reduce sequencing needs while scaling experiments.

CRISPR Detect:Supports sensitive gRNA detection with gene expression in up to 1 million cells per experiment.

GigaLab:Provides single cell sequencing services for projects involving 10 million+ cells.

Trailmaker:A user-friendly platform for streamlined single cell RNA-seq data analysis.

Specialties

Single Cell Sequencing Combinatorial Barcoding Technology Whole Transcriptome Analysis Immune Profiling CRISPR Screening Data Analysis Software

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series C and Debt T: - FT: Series C and Debt	A: 50000000 MR: - FA: 50 million FAN: 50000000	D: 2023-12-14 FD: 2023-12-14	7 investors

Series C and Debt Latest

2023-12-14

$50.0M

7 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Alex Rosenberg

CEO and Cofounder

C

Charlie Roco

CTO and Cofounder

Recent News